These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 18571006)

  • 1. KIR and HLA gene combinations in Vogt-Koyanagi-Harada disease.
    Levinson RD; Du Z; Luo L; Holland GN; Rao NA; Reed EF; Rajalingam R
    Hum Immunol; 2008 Jun; 69(6):349-53. PubMed ID: 18571006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA class II genes in Vogt-Koyanagi-Harada disease.
    Islam SM; Numaga J; Fujino Y; Hirata R; Matsuki K; Maeda H; Masuda K
    Invest Ophthalmol Vis Sci; 1994 Oct; 35(11):3890-6. PubMed ID: 7928186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The association of HLA-DR4 gene subtypes with Vogt-Koyanagi-Harada syndrome].
    Xiao T; Jiang Y; You X
    Zhonghua Yan Ke Za Zhi; 1997 Jul; 33(4):268-71. PubMed ID: 10451958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-DRB1 and -DQB1 alleles in mestizo patients with Vogt-Koyanagi-Harada's disease in Southern California.
    Levinson RD; See RF; Rajalingam R; Reed EF; Park MS; Rao NA; Holland GN
    Hum Immunol; 2004 Dec; 65(12):1477-82. PubMed ID: 15603876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of KIR genes and HLA-C in Vogt-Koyanagi-Harada disease in Saudi Arabia.
    Sheereen A; Gaafar A; Iqneibi A; Eldali A; Tabbara KF; Adra C; Al-Hussein K
    Mol Vis; 2011; 17():3523-8. PubMed ID: 22219647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of HLA-DRB1 gene variation on the clinical course of Vogt-Koyanagi-Harada disease.
    Islam SM; Numaga J; Matsuki K; Fujino Y; Maeda H; Masuda K
    Invest Ophthalmol Vis Sci; 1994 Feb; 35(2):752-6. PubMed ID: 7906684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Association of HLA-DRB genes with Vogt-Koyanagi-Harada syndrome in a Chinese Han population].
    Zhang M; Qiu C; Hu T
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Feb; 22(1):36-40. PubMed ID: 12903490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KIR and HLA Genotypes Implicated in Reduced Killer Lymphocytes Immunity Are Associated with Vogt-Koyanagi-Harada Disease.
    Levinson RD; Yung M; Meguro A; Ashouri E; Yu F; Mizuki N; Ohno S; Rajalingam R
    PLoS One; 2016; 11(8):e0160392. PubMed ID: 27490240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-DR is strongly associated with Vogt-Koyanagi-Harada disease in Mexican Mestizo patients.
    Arellanes-García L; Bautista N; Mora P; Ortega-Larrocea G; Burguet A; Gorodezky C
    Ocul Immunol Inflamm; 1998 Jun; 6(2):93-100. PubMed ID: 9689639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of human leukocyte antigen HLA-DR beta amino acid sequence in Vogt-Koyanagi-Harada syndrome.
    Numaga J; Matsuki K; Tokunaga K; Juji T; Mochizuki M
    Invest Ophthalmol Vis Sci; 1991 Jun; 32(7):1958-61. PubMed ID: 2055689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA and KIR frequencies in Sicilian Centenarians.
    Listì F; Caruso C; Colonna-Romano G; Lio D; Nuzzo D; Candore G
    Rejuvenation Res; 2010; 13(2-3):314-8. PubMed ID: 20426625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis.
    Lorentzen AR; Karlsen TH; Olsson M; Smestad C; Mero IL; Woldseth B; Sun JY; Senitzer D; Celius EG; Thorsby E; Spurkland A; Lie BA; Harbo HF
    Ann Neurol; 2009 Jun; 65(6):658-66. PubMed ID: 19630074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between Vogt-Koyanagi-Harada syndrome and HLA-DR1 and -DR4 in Hispanic patients living in southern California.
    Weisz JM; Holland GN; Roer LN; Park MS; Yuge AJ; Moorthy RS; Forster DJ; Rao NA; Terasaki PI
    Ophthalmology; 1995 Jul; 102(7):1012-5. PubMed ID: 9121744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A shared HLA-DRB1 epitope in the DR beta first domain is associated with Vogt-Koyanagi-Harada syndrome in Indian patients.
    Tiercy JM; Rathinam SR; Gex-Fabry M; Baglivo E
    Mol Vis; 2010 Mar; 16():353-8. PubMed ID: 20216938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KIR/HLA gene combinations influence susceptibility to B-cell chronic lymphocytic leukemia and the clinical course of disease.
    Karabon L; Jedynak A; Giebel S; Wołowiec D; Kielbinski M; Woszczyk D; Kapelko-Slowik K; Kuliczkowski K; Frydecka I
    Tissue Antigens; 2011 Aug; 78(2):129-38. PubMed ID: 21726204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Killer cell immunoglobulin-like receptor gene-cluster 3DS1-2DL5-2DS1-2DS5 predisposes susceptibility to Vogt-Koyanagi-Harada syndrome in Japanese individuals.
    Levinson RD; Okada AA; Ashouri E; Keino H; Rajalingam R
    Hum Immunol; 2010 Feb; 71(2):192-4. PubMed ID: 19897003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA typing in Vogt-Koyanagi-Harada syndrome in North Indian patients.
    Gupta A; Kamal S; Gupta V; Bambery P; Kaura B
    Ocul Immunol Inflamm; 2007; 15(2):89-97. PubMed ID: 17558833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vogt-Koyanagi-Harada syndrome in patients with Cherokee Indian ancestry.
    Davis J
    Am J Ophthalmol; 1993 May; 115(5):688. PubMed ID: 8488934
    [No Abstract]   [Full Text] [Related]  

  • 19. HLA-DRB1 among patients with Vogt-Koyanagi-Harada disease in Saudi Arabia.
    Iqniebi A; Gaafar A; Sheereen A; Al-Suliman A; Mohamed G; Al-Hussein K; Tabbara KF
    Mol Vis; 2009 Sep; 15():1876-80. PubMed ID: 19756183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms of FCRL3 in a Chinese population with Vogt-Koyanagi-Harada (VKH) syndrome.
    Li K; Yang P; Zhao M; Hou S; Du L; Zhou H; Kijlstra A
    Mol Vis; 2009 May; 15():955-61. PubMed ID: 19452015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.